Al Hamed, R., Labopin, M., Daguindau, E., Niittyvuopio, R., Huynh, A., Socié, G., Srour, M., Henri Bourhis, J., Kröger, N., Tholouli, E., Choi, G., Poiré, X., Martin, H., Rubio, M., Jindra, P., Blaise, D., Beelen, D., Labussière‐Wallet, H., Nagler, A., Bazarbachi, A., & Mohty, M. (2022). measurable residual disease, FLT3‐ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1‐mutated acute myeloid leukemia. Cancer medicine, 11, 1068–1080. http://access.bl.uk/ark:/81055/vdc_100152281091.0x000017